This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Approval for a manufacturing site located at roche diagnostics gmbh in mannheim, germany.
Device | ELECSYS ANTI-HBC IMMUNOASSAY ON THE ELECSYS 2010 IMMUNOASSAY ANALYZER |
Classification Name | Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm) |
Generic Name | Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm) |
Applicant | ROCHE DIAGNOSTICS CORP. |
Date Received | 2011-08-17 |
Decision Date | 2011-09-23 |
PMA | P100032 |
Supplement | S003 |
Product Code | LOM |
Advisory Committee | Microbiology |
Supplement Type | Normal 180 Day Track No User Fee |
Supplement Reason | Location Change - Manufacturer/sterilizer/packager/supplier |
Expedited Review | No |
Combination Product | No |
Applicant Address | ROCHE DIAGNOSTICS CORP. 9115 Hague Rd. indianapolis, IN 46250 |
Supplement Number | Date | Supplement Type |
---|---|---|
P100032 | Original Filing | |
S021 | 2021-09-30 | Normal 180 Day Track |
S020 | 2018-10-26 | Normal 180 Day Track No User Fee |
S019 | 2018-10-09 | 30-day Notice |
S018 | 2018-03-01 | Real-time Process |
S017 | 2017-10-11 | Real-time Process |
S016 | 2017-08-03 | 30-day Notice |
S015 | 2017-05-24 | 30-day Notice |
S014 | 2017-02-21 | Normal 180 Day Track |
S013 | 2016-02-16 | 30-day Notice |
S012 | 2016-01-27 | 30-day Notice |
S011 | 2016-01-27 | 135 Review Track For 30-day Notice |
S010 | 2015-10-07 | 30-day Notice |
S009 | 2013-04-09 | Real-time Process |
S008 | 2012-11-30 | 30-day Notice |
S007 | 2012-09-04 | Normal 180 Day Track |
S006 | 2012-02-29 | 30-day Notice |
S005 | 2012-01-31 | 135 Review Track For 30-day Notice |
S004 | 2011-08-29 | 135 Review Track For 30-day Notice |
S003 | 2011-08-17 | Normal 180 Day Track No User Fee |
S002 | 2011-08-17 | 135 Review Track For 30-day Notice |
S001 | 2011-07-01 | 30-day Notice |